It will be $15+ with TLD as nvcr is at 11 billion with just 300 million revenue. Nwbo will capture GBM and solid tumors market. Merck is already there and may be BMY and Amgen.
Hi Marzan - Have you seen the Yervoy and Opdivo combination TV commercials? airing recently in Atlanta?
BMS talks about the benefits of Yervoy and Opdivo in extending life for about 20 second. The balance of the commercial is a long list of the side effects including death!
With DCVax and Direct no side effects. Any day now we will hear of ground breaking cure for 20% or more trial participants and life extension of many more using DCVAX.
13 years of data, a strong IP position and manufacturing that soon will be automated. How could NWBO not be a forever stock for all of us to hold for a lifetime!
Market Data 
Markets 
AI
